Rep. Ro Khanna

Maddy summaryHR 4396, the Uterine Cancer Study Act of 2025, mandates a study by the Department of Health and Human Services (HHS) into the potential link between chemical hair straighteners and uterine cancer, with a specific focus on higher incidence rates among women of color. The study will review existing research, examine impacts across all racial and ethnic groups, analyze different hair straightener types (including those with dyes or bleach), and assess whether the FDA should require additional safety testing for these products. HHS must submit its study methodology within 45 days of the bill's enactment, begin the study within 180 days, and deliver a final report to Congress within two years. This bill does not create new regulations but directs a specific research effort to gather evidence on a potential health concern. The study directly affects women, particularly women of color, who use hair straightening products and may face elevated uterine cancer risks.

Maddy summaryThis bill would allow states to create their own universal health care systems by applying for waivers that replace federal health programs with state-based coverage. States would need to demonstrate they can cover at least 95% of residents within 5 years, maintain comparable benefits and affordability, and provide comprehensive coverage including reproductive health services. The federal government would redirect funds that would have gone to federal programs like Medicaid and Medicare to the states, with states required to submit regular reports on coverage progress and costs. The bill includes specific protections for Indian health care providers and ensures coverage for vulnerable populations without imposing new costs on them. This framework would apply to states that choose to implement their own universal health care system rather than relying on existing federal programs.

Maddy summaryThis bill directs the Department of Health and Human Services to significantly increase federal research funding for uterine fibroids ($30 million annually from 2026-2030), expand coordination of NIH research, and establish a Medicaid data system to track treatment access and costs. It mandates public education on fibroid symptoms, prevalence (especially among Black women, who face higher risk and severity), and non-hysterectomy treatment options. The bill also requires disseminating evidence-based provider resources on managing fibroids while preserving fertility. These provisions directly affect the estimated 26 million U.S. women with fibroids - particularly women of color - and aim to address the current lack of research and treatment data.

Maddy summaryThis bill directs the Health and Human Services Secretary to fund research on early detection and intervention for uterine fibroids, aiming to develop evidence-based approaches for healthcare settings. It authorizes grants to states to support screening (including advanced imaging), patient navigation services, and public education campaigns focused on early detection, with priority given to areas with socially vulnerable populations at higher risk. The bill also funds research into disparities in pain management during fibroid surgery and conditions like Asherman’s Syndrome. These provisions directly affect women with uterine fibroids, particularly in underserved communities, by expanding access to early detection services and targeted research.

Maddy summaryHR 4361, the STOP China Act, prohibits the use of federal transportation funds to purchase vehicles or related infrastructure (like charging stations for buses) from companies linked to China. Specifically, it bans federal funding for "covered vehicles" made by entities owned or controlled by China (as defined by the bill), including those using Chinese-made electric powertrains. The U.S. Trade Representative must publish and update a public list of these banned entities within 30 days of the bill’s enactment, with updates every 90 days initially and annually thereafter. Exceptions apply only for vehicle safety testing, inspections, or research. The bill directly affects federal transportation projects and contractors receiving federal funds, requiring them to avoid procurement from listed Chinese-connected companies.

Maddy summaryHRES 575 is a symbolic resolution designating July 10th as "Journeyman Lineworkers Recognition Day." It honors lineworkers who face significant risks daily - working at heights near live wires and responding to disasters like hurricanes and wildfires. The resolution specifically references Henry Miller, an early leader of the International Brotherhood of Electrical Workers, who died on July 10, 1896, while troubleshooting an outage. It encourages the public to recognize these workers' contributions but does not create new laws or allocate funding.

Maddy summaryThis bill requires the FDA's Office of Food Chemical Safety to reassess the safety of at least 10 food additives or related substances every three years starting in 2026. It specifically prioritizes substances like titanium dioxide, red dye 40, BHA, BHT, and sodium nitrite for initial review. If reassessments find substances unsafe, the FDA must update regulations, revoke approvals, or require new pre-market notifications. The law affects food manufacturers by mandating regular safety reviews of additives already in use, with results made public through FDA notices.

Maddy summaryThe PBM Reform Act of 2025 aims to increase transparency and fairness in pharmacy benefit manager (PBM) operations within Medicare Part D and Medicaid programs. The bill requires Medicare Part D plans to allow any pharmacy meeting standard terms to join their networks, establishes "essential retail pharmacies" in underserved areas (with limited pharmacy access), and mandates detailed reporting on drug pricing, rebates, and reimbursement rates. It creates a process for pharmacies to report PBM violations of reasonable contract terms and prohibits "spread pricing" in Medicaid, where PBMs retain the difference between what they pay pharmacies and what they charge plans. These provisions aim to improve pharmacy access for Medicare beneficiaries and ensure fairer reimbursement practices for pharmacies.

Maddy summaryHRES 550 is a non-binding House resolution recognizing June 2025 as LGBTQIA+ Pride Month. It formally encourages all U.S. citizens to celebrate Pride Month to learn about LGBTQIA+ history, including the Stonewall Inn and Compton's Cafeteria uprisings. The resolution affirms that LGBTQIA+ rights are human rights and emphasizes the ongoing struggle for equality. It has no legal effect but serves as a symbolic statement of support for the LGBTQIA+ community and its history.

Maddy summaryHRES 543 is a symbolic House resolution (not a law) introduced by multiple representatives. It affirms the constitutional right to peaceful protest under the First Amendment and condemns violent acts by some individuals during demonstrations, such as vandalism and looting. The resolution specifically criticizes the President’s 2025 deployment of National Guard and Marines to Los Angeles without proper legal authority (violating 10 U.S.C. § 12406 and the Posse Comitatus Act) and without coordination with California’s governor. It also denounces inflammatory rhetoric that escalated tensions and supports law enforcement efforts to protect public safety during protests. The resolution has no binding effect but formally expresses congressional position on these issues.